X

Arvind Remedies Ltd Stock Analysis

Small Cap
Evaluated by 751 users | BSE: 531823 | NSE: ARVINDREM |
Pharmaceuticals & Drugs
Arvind Remedies forayed into the world of quality healthcare in 1988 under the dynamic and ambitious stewardship of Arvind Shah, Managing Director and Chief Executive Officer. The company was incorporated as a private limited company and started manufacturing and marketing of world-class...

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Value Creation
 Mar'06Mar'07Mar'08Mar'09Mar'10Mar'11Mar'12Mar'13Mar'14Jun'15
Return on Capital Employed 7.46%8.09%8.07%8.75%11.11%10.85%9.57%13.44%13.96%-34.63%
Growth Parameters
Growth Parameters Colour Code Guide
Net Sales (Rs. Cr.) 144157176218298363437664911630
Y-o-Y Gr. Rt.-8.8%12.2%24%36.7%21.8%20.4%52.1%37.2%-30.9%
Adjusted EPS (Rs.) 1.251.681.981.674.083.54.028.48.64-38.56
Y-o-Y Gr. Rt.-34.4%17.9%-15.7%144.3%-14.2%14.9%109%2.9%-546.3%
Book Value per Share (Rs.) 14.7515.8517.2418.522.0125.2128.1435.439.94-5.83
Adjusted Net Profit 3.34.45.24.410.616.919.440.558.9-263
Net Op. Cash Flow (Rs. Cr.) -8.610.116-13-7.712.1713.3-60.3-121
Debt to Cash Flow from Ops -6.598.445.41-7.99-15.915.185239.15-10.34-4.96
Standalone financials take only the parent company into account while consolidated financials take into account financials of the parent company as well as of all its subsidiaries. In most companies consolidated financials should be used for analysis.
Arvind Remedies Ltd. should be analysed on a Standalone basis
CAGR
CAGR Colour Code Guide
  9 yrs 5 yrs 3 yrs 1 yr
Net Sales 17.8%16.2%13%-30.9%
Adjusted EPS -246.4%-256.7%-312.5%-546.3%
Book Value per Share -190.2-176.7-159.2-114.6
Share Price - - - -
Key Financial Parameter
Performance Ratio Colour Code Guide
 Mar'06Mar'07Mar'08Mar'09Mar'10Mar'11Mar'12Mar'13Mar'14Jun'15
Return on Equity (%) 8.6610.9811.969.3714.8515.6214.642424.85-276.95
Operating Profit Margin (%) 7.588.649.119.0710.4911.3815.5320.1319.42-5.48
Net Profit Margin (%) 2.262.792.9323.564.664.446.16.46-41.73
Debt to Equity 1.482.061.932.162.151.512.673.052.29-15.1
Working Capital Days 174183182192186225229211225270
Cash Conversion Cycle 125138122123118124145131130212
Entity Percentage Holding
Promoters 3.58%
Institutions 0.02%
Non-Institutions 96.41%
Pledged *0.0030.4536.8928.8655.7799.5999.5999.5999.5999.59
* Pledged shares as % of Promoter's holding (%)
Data is not available for this company.

Data is not available for this company.

Data is not available for this company

Arvind Remedies forayed into the world of quality healthcare in 1988 under the dynamic and ambitious stewardship of Arvind Shah, Managing Director and Chief Executive Officer.

The company was incorporated as a private limited company and started manufacturing and marketing of world-class allopathic and ayurvedic pharmaceutical products within and outside India, thus beginning to realise the vision of bringing high quality healthcare to the common man. Having grown notably in terms of

Arvind Remedies forayed into the world of quality healthcare in 1988 under the dynamic and ambitious stewardship of Arvind Shah, Managing Director and Chief Executive Officer.

The company was incorporated as a private limited company and started manufacturing and marketing of world-class allopathic and ayurvedic pharmaceutical products within and outside India, thus beginning to realise the vision of bringing high quality healthcare to the common man. Having grown notably in terms of production capacity, product categories, market share, advancements in R&D, market reach and global acceptance, the company is today a significant force to reckon with in the Indian pharmaceutical industry.

The company entered the field at a time when the Indian pharmaceutical industry was itself at the threshold of a new era, where product patenting and holistic healthcare were gaining prominence. The company’s core strength aptly lay in the ability to deliver both Western and Eastern varieties of quality treatments. Significant contributions have been made to the fields of cardiology, dermatology, nephrology and diabetes, among others. Having established its credibility as a company committed to providing world-class healthcare products, Arvind Remedies went public in April 1996 getting listed on the Bombay, Ahmedabad and Chennai Stock Exchanges. The public issue comprised of 30 lakh equity shares of Rs 10 each, at a premium of Rs 20 per share.

The company has also won international acceptance and recognition with exports to Africa, Commonwealth of Independent States and Asian countries.

Spread across 40,000 sq ft of own land, on which the built area is 30,000 sq ft, Arvind Remedies’ infrastructure and facilities are among the best and most modern in the world. ARL's state-of-the-art manufacturing facility and sophisticated research & development lab, located in the SIDCO Industrial area at Kakkalur, 45 km from Chennai, has been certified with GMP, under WHO norms. This factory manufactures pharmaceutical products in various dosages, like tablets, capsules, liquids, ointments, creams, suspensions, dry syrups, in addition to ayurvedic and herbal products.

Arvind Remedies has a sophisticated R&D lab well-equipped with instruments like HPLC, FTIR, UV Spectro Photo Meter, Dissolution Apparatus, Auto Titrator, Metler Balances, Digital DT Machine, etc. Focus areas are development of drug delivery systems, new formulations, process development of various dosage forms.

Products:

1. Allopathic

• Ethical Products  • Branded Generic Products • Generic Products

2. Ayurvedic

• Artin oil • Hygenex • Pankare • Pankare (Tab.) • Solufat • Sorexil • Stresof • Utritone

Clients:

• Defence establishments • ESI • CGHS • Central and state government institutions • Public sector companies • P&T • Railways, and • World Bank Projects.

Awards/ Recognition

  • 2010
    Arvind Remedies Ltd - Kakkalur, Thiruvallore manufacturing unit has been awarded Tamil Nadu Govt State Safety Award for the year 2010 from the Industrial Safety & Health, Tamil Nadu.
  • 2011-12
    Arvind Remedies Ltd has been awarded pioneers Award for Excellence in Healthcare 2012 from the Ministry of Health & Family Welfare in association with FICCI.
    Excellence Award received by Dr. B. Arvind Shah, MD and CEO from His Excellency the Governor of Tamil Nadu, V. Rosaiah for his contribution to the pharmaceutical industry for the year 2011-12.
Puchho Befikar
SEBI Registered: Investment Adviser - INA000013323

Callback